How Patanjali Grew Despite FSSAI Action and Legal Challenges | Explained

Multiple products linked to Patanjali Ayurved came under regulatory and legal scrutiny between 2015 and 2025, even as the company reported significant growth in revenue and net worth during the same period.

Between 2015 and 2025, serious questions were raised by the Food Safety and Standards Authority of India and various courts regarding numerous products associated with Patanjali. In several instances, products such as mustard oil, ghee, red chili powder, Amla juice, dental powder, and medicines were found to have failed quality tests or were deemed to be in violation of regulations.

In some cases, complaints emerged regarding misbranding, unauthorized product launches, false claims, and substandard quality. Notably, in 2016, a Haridwar court imposed a fine for misbranding; in 2024, the licenses for 14 products were suspended; and in 2025, a fine exceeding ₹1 lakh was levied after samples of ghee failed quality tests. Furthermore, in 2024, three individuals received prison sentences in connection with the Soan Papdi case. Cumulatively, fines totaling over ₹12.8 lakh were imposed across these various cases, and several matters even reached the Supreme Court of India.

At the same time, the company’s business expanded significantly. Starting from approximately ₹100 crore in 2011, revenue surged to ₹10,216 crore in 2016–17. By FY2024, revenue remained above the ₹9,000 crore mark, while total net worth was recorded at over ₹59,000 crore.

The data reflects a contrast between regulatory actions and financial performance, with the company’s market growth continuing despite repeated scrutiny and penalties over the years.